| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 5 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.97M | $1.18M | - | |
| Dir | 521.7K | $311.5K | - | |
| COO | 401.8K | $239.9K | - | |
| CEO | 63.9K | $38.2K | - | |
| Dir | 28.4K | $17.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2019 | Strayer David R | Chief Science/ Medical Officer | Buy | 2,481 | $4.03 | $9,998.43 | +84.4% | |
| Jun 21, 2019 | Rodino III Peter W. | Dir Govt Relations/ Sectry | Buy | 8,695 | $4.03 | $35,040.85 | +223.2% | |
| Jun 21, 2019 | Springate Wayne S | Sr. VP Of Operations | Buy | 5,211 | $4.03 | $21,000.33 | +150.6% | |
| Jun 21, 2019 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 29,404 | $4.03 | $118,498.12 | +2.2% | |
| Jun 21, 2019 | Appelrouth Stewart | Director | Buy | 9,677 | $4.03 | $38,998.31 | +56.8% | |
| Jun 21, 2019 | Mitchell William M | Director | Buy | 9,677 | $4.03 | $38,998.31 | +86.7% | |
| Mar 19, 2019 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 13,400 | $0.18 | $2,351.70 | +1.7% | |
| Nov 30, 2018 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 20,000 | $0.19 | $3,844.99 | +0.3% | |
| Nov 5, 2018 | Appelrouth Stewart | Director | Buy | 25,238 | $0.22 | $5,552.36 | +10.4% | |
| Oct 26, 2018 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 3,500 | $0.20 | $710.50 | +0.5% |